Headlines

Fate Therapeutics And Canaan On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Fate Therapeutics, MSCI, and Educational Development Corporation.

Rank Financial Asset Price Change Updated (EST)
1 Fate Therapeutics (FATE) 5.72 25.44% 2024-01-30 07:11:08
2 MSCI (MSCI) 602.45 9.35% 2024-01-30 15:56:38
3 Educational Development Corporation (EDUC) 1.62 8.72% 2024-01-30 01:08:05
4 General Motors (GM) 38.11 7.69% 2024-01-30 15:54:57
5 Cyclacel Pharmaceuticals (CYCC) 2.28 7.55% 2024-01-29 19:07:06
6 Sysco Corporation (SYY) 80.69 7.35% 2024-01-30 15:58:41
7 Nucor Corporation (NUE) 188.99 6.99% 2024-01-30 15:22:07
8 Cliffs Natural Resources (CLF) 20.12 6.54% 2024-01-30 15:53:36
9 Corning Incorporated (GLW) 33.14 6.39% 2024-01-30 15:20:48
10 eHealth (EHTH) 7.14 6.01% 2024-01-30 01:23:06

The three biggest losers today are Canaan, Eltek Ltd., and iRobot.

Rank Financial Asset Price Change Updated (EST)
1 Canaan (CAN) 1.48 -9.76% 2024-01-30 15:16:22
2 Eltek Ltd. (ELTK) 17.69 -9.28% 2024-01-30 01:42:06
3 iRobot (IRBT) 14.23 -8.2% 2024-01-30 15:13:30
4 UPS (UPS) 145.15 -8.14% 2024-01-30 15:59:28
5 Schlumberger (SLB) 49.17 -7.58% 2024-01-30 15:58:23
6 Inovio Pharmaceuticals (INO) 5.81 -6.89% 2024-01-30 15:13:21
7 Rumble (RUM) 6.08 -6.32% 2024-01-30 15:23:52
8 Nikola (NKLA) 0.75 -6.01% 2024-01-30 14:17:50
9 Virgin Galactic (SPCE) 1.81 -5.99% 2024-01-30 14:01:19
10 Wayfair (W) 51.81 -5.71% 2024-01-30 15:59:42

Winners today

1. Fate Therapeutics (FATE) – 25.44%

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

NASDAQ ended the session with Fate Therapeutics jumping 25.44% to $5.72 on Tuesday while NASDAQ fell 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Fate Therapeutics has a trailing twelve months EPS of $-1.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.61%.

Moving Average

Fate Therapeutics’s worth is way higher than its 50-day moving average of $3.40 and way above its 200-day moving average of $3.72.

More news about Fate Therapeutics.

2. MSCI (MSCI) – 9.35%

MSCI Inc., together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. It operates through four segments: Index, Analytics, ESG and Climate, and All Other – Private Assets. The Index segment provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, and service that provides an integrated view of risk and return, and an analysis of market, credit, liquidity, and counterparty risk across asset classes; managed services, including consolidation of client portfolio data from various sources, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG factors impact the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other – Private Assets segment includes real estate market and transaction data, benchmarks, return-analytics, climate assessments and market insights for funds, investors, and managers; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. It serves asset owners and managers, financial intermediaries, wealth managers, real estate professionals, and corporates. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

NYSE ended the session with MSCI rising 9.35% to $602.45 on Tuesday while NYSE rose 0.3% to $17,092.37.

MSCI (msci) Q4 earnings and revenues top estimatesWhile MSCI has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

MSCI (msci) Q4 earnings: taking a look at key metrics versus estimatesHere is how MSCI performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, MSCI has a trailing twelve months EPS of $12.01.

PE Ratio

MSCI has a trailing twelve months price to earnings ratio of 50.16. Meaning, the purchaser of the share is investing $50.16 for every dollar of annual earnings.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Nov 7, 2023, the estimated forward annual dividend rate is 5.52 and the estimated forward annual dividend yield is 1%.

More news about MSCI.

3. Educational Development Corporation (EDUC) – 8.72%

Educational Development Corporation, a publishing company, operates as a trade co-publisher of educational children's books in the United States. It operates through two segments, Publishing and Usborne Books & More (UBAM). The company offers various books, including touchy-feely board books, activity books and flashcards, adventure and search books, art books, sticker books, and foreign language books, as well as internet-linked books comprising science and math titles, and chapter books and novels. Educational Development Corporation markets its products to retail accounts, which include book, school supply, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers, and its internal tele-sales group; and through a network of independent sales consultants through internet sales, direct sales, home shows, and book fairs. Educational Development Corporation was incorporated in 1965 and is headquartered in Tulsa, Oklahoma.

NASDAQ ended the session with Educational Development Corporation rising 8.72% to $1.62 on Tuesday while NASDAQ dropped 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Educational Development Corporation has a trailing twelve months EPS of $0.02.

PE Ratio

Educational Development Corporation has a trailing twelve months price to earnings ratio of 81. Meaning, the purchaser of the share is investing $81 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.51%.

More news about Educational Development Corporation.

4. General Motors (GM) – 7.69%

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. The company also sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. In addition, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties; and safety and security services for retail and fleet customers, including automatic crash response, emergency services, roadside assistance, crisis assist, stolen vehicle assistance, and turn-by-turn navigation. Further, the company provides connected services comprising mobile applications for owners to remotely control their vehicles and electric vehicle owners to locate charging stations, on-demand vehicle diagnostics, GM Smart Driver, Amazon Alexa in-vehicle voice, Google's Voice Assistant, navigation and app ecosystem, connected navigation, SiriusXM with 360L, and 4G LTE wireless connectivity. Additionally, the company provides automotive financing and insurance services; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

NYSE ended the session with General Motors jumping 7.69% to $38.11 on Tuesday while NYSE jumped 0.3% to $17,092.37.

General Motors company (gm) reports Q4 earnings: what key metrics have to sayFor the quarter ended December 2023, General Motors Company (GM Quick QuoteGM – Free Report) reported revenue of $42.98 billion, down 0.3% over the same period last year. , Here is how General Motors Company performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, General Motors has a trailing twelve months EPS of $7.12.

PE Ratio

General Motors has a trailing twelve months price to earnings ratio of 5.35. Meaning, the purchaser of the share is investing $5.35 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.27%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 1.02%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, General Motors’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

General Motors’s stock is valued at $38.11 at 16:32 EST, way under its 52-week high of $43.63 and way higher than its 52-week low of $26.30.

Volume

Today’s last reported volume for General Motors is 51726500 which is 158.51% above its average volume of 20009000.

More news about General Motors.

5. Cyclacel Pharmaceuticals (CYCC) – 7.55%

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise Sapacitabine, an orally available prodrug of CNDAC, which is a novel nucleoside analog. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.

NASDAQ ended the session with Cyclacel Pharmaceuticals rising 7.55% to $2.28 on Tuesday while NASDAQ dropped 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Cyclacel Pharmaceuticals has a trailing twelve months EPS of $-29.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -187.4%.

Volume

Today’s last reported volume for Cyclacel Pharmaceuticals is 234741 which is 50.58% above its average volume of 155884.

More news about Cyclacel Pharmaceuticals.

6. Sysco Corporation (SYY) – 7.35%

Sysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. It operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. The company distributes frozen food, such as meat, seafood, fully prepared entrées, fruits, vegetables, and desserts; canned and dry food products; fresh meat and seafood products; dairy products; beverages; imported specialties; and fresh produce products. It also supplies various non-food items, including paper products comprising disposable napkins, plates, and cups; tableware consisting of glassware and silverware; cookware, such as pots, pans, and utensils; restaurant and kitchen equipment and supplies; and cleaning supplies. The company serves restaurants, hospitals and nursing facilities, schools and colleges, hotels and motels, industrial caterers, and other foodservice venues. Sysco Corporation was incorporated in 1969 and is headquartered in Houston, Texas.

NYSE ended the session with Sysco Corporation jumping 7.35% to $80.69 on Tuesday, after two sequential sessions in a row of gains. NYSE rose 0.3% to $17,092.37, after three successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Sysco Corporation has a trailing twelve months EPS of $3.55.

PE Ratio

Sysco Corporation has a trailing twelve months price to earnings ratio of 22.73. Meaning, the purchaser of the share is investing $22.73 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 109.34%.

Yearly Top and Bottom Value

Sysco Corporation’s stock is valued at $80.69 at 16:32 EST, below its 52-week high of $82.38 and way above its 52-week low of $62.24.

Volume

Today’s last reported volume for Sysco Corporation is 6169850 which is 103.65% above its average volume of 3029570.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 76.82B for the twelve trailing months.

More news about Sysco Corporation.

7. Nucor Corporation (NUE) – 6.99%

Nucor Corporation engages in manufacture and sale of steel and steel products. The company's Steel Mills segment produces hot-rolled, cold-rolled, and galvanized sheet steel products; plate steel products; wide-flange beams, beam blanks, and H-piling and sheet piling products; and bar steel products, such as blooms, billets, concrete reinforcing and merchant bars, and engineered special bar quality products. It also engages in the steel trading and rebar distribution businesses. This segment sells its products to steel service centers, fabricators, and manufacturers in the United States, Canada, and Mexico. Its Steel Products segment offers hollow structural section steel tubing products, electrical conduits, steel racking, steel joists and joist girders, steel decks, fabricated concrete reinforcing steel products, cold finished steel products, steel fasteners, metal building systems, insulated metal panels, steel grating and expanded metal products, and wire and wire mesh products primarily for use in nonresidential construction applications. This segment also engages in the piling distribution business. The company's Raw Materials segment produces direct reduced iron (DRI); brokers ferrous and nonferrous metals, pig iron, hot briquetted iron, and DRI; supplies ferro-alloys; and processes ferrous and nonferrous scrap metal. This segment sells its ferrous scrap to electric arc furnace steel mills and foundries for manufacturing process; and nonferrous scrap metal to aluminum can producers, secondary aluminum smelters, steel mills and other processors, and consumers of various nonferrous metals. It serves agriculture, automotive, construction, energy and transmission, oil and gas, heavy equipment, infrastructure, and transportation industries through its in-house sales force; and internal distribution and trading companies. The company was founded in 1905 and is headquartered in Charlotte, North Carolina.

NYSE ended the session with Nucor Corporation rising 6.99% to $188.99 on Tuesday, after five successive sessions in a row of gains. NYSE rose 0.3% to $17,092.37, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Nucor Corporation has a trailing twelve months EPS of $19.77.

PE Ratio

Nucor Corporation has a trailing twelve months price to earnings ratio of 9.56. Meaning, the purchaser of the share is investing $9.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.61%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nucor Corporation’s stock is considered to be oversold (<=20).

More news about Nucor Corporation.

8. Cliffs Natural Resources (CLF) – 6.54%

Cleveland-Cliffs Inc. operates as a flat-rolled steel producer in North America. The company offers hot-rolled, cold-rolled, electrogalvanized, hot-dip galvanized, galvannealed, aluminized, galvalume, enameling, and advanced high-strength steel products; stainless steel products; plates; and grain oriented and non-oriented electrical steel products. It also provides tubular components, including carbon steel, stainless steel, and electric resistance welded tubing. In addition, the company offers tinplate products, such as electrolytic tin coated and chrome coated sheet, and tin mill products; tooling and sampling; raw materials; ingots, rolled blooms, and cast blooms; and hot-briquetted iron products. Further, it owns five iron ore mines in Minnesota and Michigan. The company serves automotive, infrastructure and manufacturing, distributors and converters, and steel producers. Cleveland-Cliffs Inc. was formerly known as Cliffs Natural Resources Inc. and changed its name to Cleveland-Cliffs Inc. in August 2017. The company was founded in 1847 and is headquartered in Cleveland, Ohio.

NYSE ended the session with Cliffs Natural Resources rising 6.54% to $20.12 on Tuesday, after four sequential sessions in a row of gains. NYSE jumped 0.3% to $17,092.37, after three sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Cliffs Natural Resources has a trailing twelve months EPS of $0.67.

PE Ratio

Cliffs Natural Resources has a trailing twelve months price to earnings ratio of 30.04. Meaning, the purchaser of the share is investing $30.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.92%.

More news about Cliffs Natural Resources.

9. Corning Incorporated (GLW) – 6.39%

Corning Incorporated engages in the display technologies, optical communications, environmental technologies, specialty materials, and life sciences businesses worldwide. The company's Display Technologies segment offers glass substrates for flat panel displays, including liquid crystal displays and organic light-emitting diodes that are used in televisions, notebook computers, desktop monitors, tablets, and handheld devices. Its Optical Communications segment provides optical fibers and cables; and hardware and equipment products, such as cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories for the telecommunications industry, businesses, governments, and individuals. The company's Specialty Materials segment manufactures products that offer material formulations for glass, glass ceramics, crystals, precision metrology instruments, and software, as well as glass wafers and substrates, tinted sunglasses, and radiation shielding products for various markets comprising mobile consumer electronics, semiconductor equipment optics and consumables, aerospace and defense optics, radiation shielding products, sunglasses, and telecommunications components. Its Environmental Technologies segment provides ceramic substrates and filter products for emissions control in mobile, gasoline, and diesel applications. The company's Life Sciences segment offers laboratory products, including consumables, such as plastic vessels, liquid handling plastics, specialty surfaces, cell culture media, and serum, as well as general labware, and glassware and equipment under the Corning, Falcon, Pyrex, and Axygen brands. Corning Incorporated was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. The company was founded in 1851 and is headquartered in Corning, New York.

NYSE ended the session with Corning Incorporated jumping 6.39% to $33.14 on Tuesday, after five successive sessions in a row of gains. NYSE rose 0.3% to $17,092.37, after three consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Corning Incorporated has a trailing twelve months EPS of $0.68.

PE Ratio

Corning Incorporated has a trailing twelve months price to earnings ratio of 48.74. Meaning, the purchaser of the share is investing $48.74 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.57%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Nov 15, 2023, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 3.63%.

Volume

Today’s last reported volume for Corning Incorporated is 8633010 which is 103.19% above its average volume of 4248570.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Corning Incorporated’s stock is considered to be oversold (<=20).

Revenue Growth

Year-on-year quarterly revenue growth declined by 9%, now sitting on 13B for the twelve trailing months.

More news about Corning Incorporated.

10. eHealth (EHTH) – 6.01%

eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company operates a marketplace that offers consumers a choice of insurance products, such as Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business, and other ancillary health insurance products from health insurance carriers. It markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers to market and distribute health insurance plans online; and provides online sponsorship and advertising, and lead referral services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.

NASDAQ ended the session with eHealth rising 6.01% to $7.14 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ fell 0.76% to $15,509.90, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, eHealth has a trailing twelve months EPS of $-3.41.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.88%.

More news about eHealth.

Losers Today

1. Canaan (CAN) – -9.76%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan sliding 9.76% to $1.48 on Tuesday while NASDAQ dropped 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.

Sales Growth

Canaan’s sales growth is negative 39% for the present quarter and negative 21% for the next.

More news about Canaan.

2. Eltek Ltd. (ELTK) – -9.28%

Eltek Ltd. manufactures, markets, and sells printed circuit boards (PCBs) in Israel, Europe, North America, India, the Netherlands, and internationally. The company offers a range of custom designed PCBs, including rigid, double-sided, and multi-layer PCBs, and flexible circuitry boards. It also offers high density interconnect, flex-rigid, and multi-layered boards. It primarily serves manufacturers of defense and aerospace, medical, industrial, telecom, and networking equipment, as well as contract electronic manufacturers and others. The company markets and sells its products primarily through direct sales personnel, sales representatives, and PCB trading and manufacturing companies. Eltek Ltd. was incorporated in 1970 and is headquartered in Petach Tikva, Israel. Eltek Ltd. is a subsidiary of Nistec Golan Ltd.

NASDAQ ended the session with Eltek Ltd. dropping 9.28% to $17.69 on Tuesday, following the last session’s downward trend. NASDAQ slid 0.76% to $15,509.90, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Eltek Ltd. has a trailing twelve months EPS of $0.99.

PE Ratio

Eltek Ltd. has a trailing twelve months price to earnings ratio of 17.87. Meaning, the purchaser of the share is investing $17.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.41%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Dec 11, 2023, the estimated forward annual dividend rate is 0.22 and the estimated forward annual dividend yield is 1.24%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.9%, now sitting on 44.85M for the twelve trailing months.

Moving Average

Eltek Ltd.’s worth is way higher than its 50-day moving average of $14.57 and way above its 200-day moving average of $9.82.

Volume

Today’s last reported volume for Eltek Ltd. is 259120 which is 154.14% above its average volume of 101957.

More news about Eltek Ltd..

3. iRobot (IRBT) – -8.2%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot falling 8.2% to $14.23 on Tuesday, after four consecutive sessions in a row of losses. NASDAQ fell 0.76% to $15,509.90, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-11.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.

Sales Growth

iRobot’s sales growth is negative 28.7% for the current quarter and 25.3% for the next.

More news about iRobot.

4. UPS (UPS) – -8.14%

United Parcel Service, Inc., a package delivery company, provides transportation and delivery, distribution, contract logistics, ocean freight, airfreight, customs brokerage, and insurance services. It operates through two segments, U.S. Domestic Package and International Package. The U.S. Domestic Package segment offers time-definite delivery of letters, documents, small packages, and palletized freight through air and ground services in the United States. The International Package segment provides guaranteed day and time-definite international shipping services comprising guaranteed time-definite express options in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company also provides international air and ocean freight forwarding, post-sales, and mail and consulting services. In addition, it offers truckload brokerage services; supply chain solutions to the healthcare and life sciences industries; financial and information services; and fulfillment and transportation management services. United Parcel Service, Inc. was founded in 1907 and is headquartered in Atlanta, Georgia.

NYSE ended the session with UPS dropping 8.14% to $145.15 on Tuesday while NYSE rose 0.3% to $17,092.37.

UPS (ups) Q4 earnings: taking a look at key metrics versus estimatesHere is how UPS performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

UPS surpasses Q4 earnings estimates, announces dividend hikeFor 2024, UPS anticipates revenues in the range of $92-$94.5 billion and consolidated adjusted operating margin to lie between 10% and 10.6%., Further, UPS anticipates dividend payments of $5.4 billion, subject to board approval.

Earnings Per Share

As for profitability, UPS has a trailing twelve months EPS of $9.88.

PE Ratio

UPS has a trailing twelve months price to earnings ratio of 14.69. Meaning, the purchaser of the share is investing $14.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.31%.

More news about UPS.

5. Schlumberger (SLB) – -7.58%

Schlumberger Limited engages in the provision of technology for the energy industry worldwide. The company operates through four divisions: Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. The company provides field development and hydrocarbon production, carbon management, and integration of adjacent energy systems; reservoir interpretation and data processing services for exploration data; and well construction and production improvement services and products. It also offers subsurface geology and fluids evaluation information; open and cased hole services; exploration and production pressure, and flow-rate measurement services; and pressure pumping, well stimulation, and coiled tubing equipment solutions. In addition, the company offers mud logging, directional drilling, measurement-while-drilling, and logging-while-drilling services, as well as engineering support services; supplies drilling fluid systems; designs, manufactures, and markets roller cone and fixed cutter drill bits; bottom-hole-assembly and borehole enlargement technologies; well cementing products and services; well planning, well drilling, engineering, supervision, logistics, procurement, and contracting of third parties, as well as drilling rig management solutions; and drilling equipment and services, as well as land drilling rigs and related services. Further, it provides artificial lift production equipment and optimization services; supplies packers, safety valves, sand control technology, and various intelligent well completions technology and equipment; designs and manufactures valves, chokes, actuators, and surface trees; and OneSubsea, an integrated solutions, products, systems, and services, including wellheads, subsea trees, manifolds and flowline connectors, control systems, connectors, and services. The company was formerly known as Socie´te´ de Prospection E´lectrique. Schlumberger Limited was founded in 1926 and is based in Houston, Texas.

NYSE ended the session with Schlumberger falling 7.58% to $49.17 on Tuesday while NYSE rose 0.3% to $17,092.37.

Earnings Per Share

As for profitability, Schlumberger has a trailing twelve months EPS of $2.91.

PE Ratio

Schlumberger has a trailing twelve months price to earnings ratio of 16.9. Meaning, the purchaser of the share is investing $16.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.73%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 14.1%, now sitting on 33.44B for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Feb 5, 2024, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 2.22%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 18.3% and 22.2%, respectively.

More news about Schlumberger.

6. Inovio Pharmaceuticals (INO) – -6.89%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals falling 6.89% to $5.81 on Tuesday, following the last session’s upward trend. NASDAQ dropped 0.76% to $15,509.90, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-7.56.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.3%.

More news about Inovio Pharmaceuticals.

7. Rumble (RUM) – -6.32%

Rumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a subscription platform for creators and subscribers to engage through VOD, podcasts, live chat, polls, and community discussions; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.

NASDAQ ended the session with Rumble sliding 6.32% to $6.08 on Tuesday while NASDAQ fell 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Rumble has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.68%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 63.7%, now sitting on 80.53M for the twelve trailing months.

More news about Rumble.

8. Nikola (NKLA) – -6.01%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola dropping 6.01% to $0.75 on Tuesday while NASDAQ dropped 0.76% to $15,509.90.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.61.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -159.83%.

More news about Nikola.

9. Virgin Galactic (SPCE) – -5.99%

Virgin Galactic Holdings, Inc. focuses on the development, manufacture, and operation of spaceships and related technologies for conducting commercial human spaceflight and flying commercial research and development payloads into space. It is also involved in the ground and flight testing, and post-flight maintenance of its spaceflight system vehicles. The company serves private individuals, researchers, and government agencies. Virgin Galactic Holdings, Inc. was founded in 2017 is headquartered in Las Cruces, New Mexico.

NYSE ended the session with Virgin Galactic falling 5.99% to $1.81 on Tuesday, after two successive sessions in a row of gains. NYSE rose 0.3% to $17,092.37, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Virgin Galactic has a trailing twelve months EPS of $-1.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -90.56%.

Sales Growth

Virgin Galactic’s sales growth is 244.1% for the ongoing quarter and 315.5% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Virgin Galactic’s EBITDA is -1.4.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 45.5% and 50.9%, respectively.

Previous days news about Virgin Galactic

  • Why Virgin Galactic (spce) outpaced the stock market today. According to Zacks on Monday, 29 January, "Analysts and investors alike will be keeping a close eye on the performance of Virgin Galactic in its upcoming earnings disclosure. "

More news about Virgin Galactic.

10. Wayfair (W) – -5.71%

Wayfair Inc. engages in the e-commerce business in the United States and internationally. The company provides approximately fourty million products for the home sector under various brands. It offers online selections of furniture, décor, housewares, and home improvement products through its sites, including Wayfair, Joss & Main, AllModern, Birch Lane, Perigold, and Wayfair Professional. The company was founded in 2002 and is headquartered in Boston, Massachusetts.

NYSE ended the session with Wayfair sliding 5.71% to $51.81 on Tuesday while NYSE jumped 0.3% to $17,092.37.

Earnings Per Share

As for profitability, Wayfair has a trailing twelve months EPS of $-8.25.

More news about Wayfair.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *